I don't know much abotu this stuff, but my impression is it isn't looking that good. "The study found that there was a statistically significant 52% reduction in viral shedding rate for vaccine recipients, when the post-vaccine period was compared with pre-vaccine, and a non-significant 31% reduction in shedding was observed over the course of the study for the subjects receiving placebo. When the extent of reduction in shedding was compared between the vaccine and the placebo groups, however, the reduction associated with vaccine was non-significant."
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-2
-
- There are more pages in this discussion • 349 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.70 |
Change
-0.300(1.58%) |
Mkt cap ! $359.4M |
Open | High | Low | Value | Volume |
$19.00 | $19.00 | $18.62 | $180.3K | 9.596K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 475 | $18.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.91 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 475 | 18.700 |
1 | 10 | 18.630 |
2 | 1027 | 18.610 |
1 | 1000 | 18.600 |
2 | 475 | 18.580 |
Price($) | Vol. | No. |
---|---|---|
18.910 | 100 | 1 |
19.500 | 21 | 1 |
20.000 | 1800 | 4 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online